NovoCure (NVCR) Change in Account Payables (2014 - 2019)

NovoCure has disclosed Change in Account Payables across 6 years of filings, most recently posting $126000.0 for Q2 2019.

• Change in Account Payables for Q2 2019 came in at $126000.0, down 87.6% year-over-year; the trailing twelve-month figure through Jun 2019 was $9.6 million (up 32.44% YoY), and the FY2018 annual result was $9.5 million, up 926.35% from the prior year.
• Change in Account Payables came in at $126000.0 for Q2 2019 at NovoCure, down from $3.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $6.7 million in Q4 2018 to a low of -$6.8 million in Q3 2016.
• The 5-year median for Change in Account Payables is $1.7 million (2015), against an average of $1.1 million.
• Peak annual rise in Change in Account Payables reached 371.28% in 2016, while the deepest fall reached 547.42% in 2016.
• NovoCure's Change in Account Payables stood at $2.4 million in 2015, then surged by 78.6% to $4.2 million in 2016, then dropped by 27.45% to $3.1 million in 2017, then jumped by 117.27% to $6.7 million in 2018, then sank by 98.11% to $126000.0 in 2019.
• The last three Change in Account Payables figures came in at $126000.0 (Q2 2019), $3.2 million (Q1 2019), and $6.7 million (Q4 2018), per Business Quant data.